Photolabeling the Binding Site of Propofol

  • Author: Melania Tesio
  • Published: 30 September 2013
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
  • Source / Publisher: Nature Chemical Biology/Nature Publishing
thumbnail image: Photolabeling the Binding Site of Propofol

Propofol, the most used intravenous general anesthetic (pictured), targets the receptors for γ-amminobutyric acid (GABA), an endogenous chemical that inhibits the transmission of nerve signals. Propofol’s exact mechanism of action, however, has not been fully elucidated because it is still unknown how this drug binds to its target receptors.

Grace Yip, Imperial College, London, UK, and colleagues clarified this issue by using a multistep approach. First, the researchers synthesized protiated and deuterated versions of ortho-propofol diazine, a propofol analogue bearing a trifluoromethyl diazirine moiety. This group is photoreactive, and upon light activation it induced the formation of an irreversible covalent binding between the drug analogue and the GABAA receptors. Subsequently, using mass spectrometry, the scientists identified the specific amino acids of the receptor that were engaged in this binding. By doing so, they discovered that propofol binds to GABAA receptors in a cavity located near the interface between the transmembrane region and the extracellular ligand binding domain.

These novel findings might help the development of new anesthetics with fewer side effects.

Article Views: 3523

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH